Sourbier C, Lindner V, lang H,et al. The Phosphoinoeitide 3-Kinase/AKT Pathway: A New Target in Human Renal Cell Carcinoma Therapy[J]. Cancer Res, 2006,66:5130-5142.
Sourbier C, Lindner V, lang H,et al. The Phosphoinoeitide 3-Kinase/AKT Pathway: A New Target in Human Renal Cell Carcinoma Therapy[J]. Cancer Res, 2006,66:5130-5142.
[5]
韩瑞发.肾癌[M].北京:人民卫生出版社,2010:466-475.
[6]
Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferonalfa in metastatic renal-cell carcinoma[J]. N Engl J Med,2007,356:115-124.
Gao N, Flynn DC, Zhang Z, et al. G1 cell cycle progression and the expression of GI cyclins are regulated by PI3K/AKT/mTOR/P70S6KI signaling in human ovarian cancer cells[J]. Am J Physiol Cell Physiol, 2004,287(2):281-291.
[9]
Shin Lee J,Seok Kim H, Bok Kim Y, et al. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth[J]. Journal of Surgical Oncology,2003, 84:166-172.
Lee SJ,Kim SH, Kim BY,et al. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth[J]. J Surg Oncol,2003,84(3):166.
[12]
Sano T,Lin H, Chen X, et al. Diferential expression of MMAC/PTEN in glioblastoma multiforme relationship to localization and prognosis[J]. Cancer Ros,1999,59:1820-1824.
Hager M, Haufe H, Kemmerling R, et al. PTEN expression in renal cell carcinoma and oncocytoma and prognosis[J]. Pathology,2007,39(5):482-485.
[15]
Schneider E, Keppler R, Prawitt D, et al. Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN[J]. Int J Oncol. 2011,38(3):823-831.
